Single agents known to be active in head and neck cancer.

Abstract

Despite good results of polychemotherapy in head and neck cancer, monochemotherapy retains a valuable role in managing patients with advanced disease. In a palliative setting, lower toxicity and simpler handling of therapy with single agents are outlined by the Authors, who review results of most active drugs in their different schedules.

• Authors: S Monfardini, A Volonterio, S Marchini
• Journal: Chemioterapia : international journal of the Mediterranean Society of Chemotherapy (Chemioterapia) Vol. 4 Issue 4 Pg. 303-9 (Aug 1985) ISSN: 0392-906X [Print] Italy
• PMID: 2414016 (Publication Type: Journal Article)

Chemical References

• Antineoplastic Agents
• Bleomycin
• Cisplatin
• Leucovorin
• Methotrexate

Topics

• Antineoplastic Agents (therapeutic use)
• Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
• Bleomycin (therapeutic use)
• Carcinoma, Squamous Cell (drug therapy)
• Cisplatin (therapeutic use)
• Head and Neck Neoplasms (drug therapy)
• Humans
• Leucovorin (therapeutic use)
• Methotrexate (therapeutic use)